SPR 2024 Annual Meeting & Postgraduate Course (On-Demand)

CME Release Date: August 15, 2024
CME Eligibility/Online Access Expiration Date: August 14, 2027

After completing this activity, the participant should be better able to:

1. Summarize the most current information on state-of-the-art pediatric imaging and intervention.
2. Describe new technologies and clinical workflow for pediatric imaging and intervention. 
3. Identify trends in pediatric radiology research regarding the care and management of pediatric patients. 
4. Discuss the need of supporting pediatric imaging at a global level and understand the global need and impact of knowledge sharing to improve the care of more children.
5. Explain the best and most up-to-date practice regarding patient safety and quality.

Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Michigan State Medical Society and the Society for Pediatric Radiology. The Michigan State Medical Society is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
The Michigan State Medical Society designates this enduring material activity for a maximum of 27.75 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Accredited CME Activity that includes Evaluation of the Learner with Feedback
This activity includes evaluation of the learner with feedback for American Board of Radiology diplomates not completing their OLA annual progress requirement.

Instructions to Receive Credit
In order to successfully complete the activity, participants must view the recorded presentations, and complete the applicable post-test and activity evaluation. You must score 80% or higher in 3 attempts in order to pass the post-tests. Once each component of the activity is complete, participants will be able to claim credit commensurate with their participation in the activity and download the credit certificate. 

Contact Information
For assistance with the administration of the activity, please contact the SPR at info@spr.org.

Disclosure of Relevant Financial Relationships
Disclosure Policy: The Society for Pediatric Radiology (SPR) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME), stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program are required to disclose all financial relationships with any ineligible company within the past 24 months.  All financial relationships reported are identified as relevant and mitigated in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted to assure objectivity and that the activity is free of commercial bias.  All relevant financial relationships have been mitigated.

The following faculty members have the following identified relevant financial relationships:

Susan J. Back, MD, FAAP - Contracted Research: Philips Healthcare | Educational Grant and Investigator Initiated Research: Bracco Diagnostics
Kim M. Cecil, PhD - Contracted Research: Myrtelle Gene Therapies; Ultragenyx Pharmaceutical
Sherwin Chan, MD, PhD - Consulting Fee: Jazz Pharmaceuticals; Deepsight Technologies | Contracted Research: GE Healthcare; Jazz Pharmaceuticals; Hyperfine
Jeremy Dahl, PhD, FAIUM - Consulting Fee: Sanmai Technologies | Research Agreement: Siemens Healthineers
Jonathan R. Dillman, MD, MSc - Contracted Research: Motilent; Siemens Healthineers; Philips Healthcare; GE Healthcare
Alan W. Flake, MD - Consulting Fee: Vitara Biomedical | Research Grant: Vitara Biomedical | Stock Options: Vitara Biomedical
Misun Hwang, MD - Investigator Initiated Grants: Bracco Diagnostics
Diego Jaramillo, MD, MPH - Consulting Fee: Pfizer
Ananth J. Madhuranthakam, PhD - Contracted Research: Philips Healthcare; Novartis Institutes for Biomedical Research
Mesha Martinez, MD - Consulting Fee: VizAI
Beth McCarville, MD - Research In-kind Support: Bracco (contrast media) and Philips Healthcare (US machine)
Arthur B. Meyers, MD - Consulting Fee: Pfizer | Royalties: Elsevier
Timothy P. Roberts, PhD - Advisory Board: Proteus Neurodynamics | Consulting Fee: Fieldline; Prism Clinical Imaging; Western Proton Therapy | Stock Shareholder: Prism Clinical Imaging; Proteus Neurodynamics | Stock Options Holder: Fieldline
Joshua Shimony, MD, PhD - Consulting Fee and Stock Options: Sora Neuroscience
Elizabeth Tang, MD - Stock Options: Thermo Fischer
Andrew T. Trout, MD - Contracted Research: Siemens Healthineers; GE Healthcare; Perspectum
Arastoo Vossough, MD, PhD - Consulting Fee: Syneos | Stock Options: DeepSight
Meng Yin, PhD - Stock Shareholder: Resoundant

All other planners, speakers, moderators, reviewers and staff have no relevant financial relationships to disclose.

Commercial Support was not received for this educational activity.

To view the SPR 2024 Annual Meeting & Postgraduate Course (On-Demand) homepage, click here.